About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Multifactorial Approach to Emergent Cerclage

NCT01114516·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Northwestern University

Age

18–80

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

GA 16+0 to 23+6 weeks
Singleton gestation
Presence of cervical dilation as diagnosed on digital examination
Intact membranes

You may not be if

Age \<18 years
Allergy to NSAIDs
Renal disease
Allergy to penicillins AND clindamycin
Currently on antibiotics or indomethacin for any reason
HIV positive
Pregnancies complicated by fetal congenital anomalies
Preterm premature rupture of membranes
Fever of 100.4 degrees Fahrenheit or higher
Any patient having received a therapeutic cerclage during the current pregnancy

The record

StatusCompleted

PhaseNo phase

Taking part53

StartedMar 2010

UpdatedNov 7, 2014

Conditions

Cervical Insufficiency

Where1

Prentice Women's Hospital
Chicago, Illinois, United States

Clareo Health | Multifactorial Approach to Emergent Cerclage